RECENT DEVELOPMENTS IN SYNTHETIC METHODS AND PHARMACOLOGICAL ACTIVITIES OF QUINAZOLINONE DERIVATIVES: A REVIEW

Omar N. Meftah1*, Ahshan Ali2, Ali G. Al-kaf1

1Pharmaceutical Medicinal and Organic Chemistry, Faculty of Pharmacy, Sana’a University, Sana’a, Yemen.

2Department of Pharmaceutical Sciences, Gurugram University, Gurugram Haryana, India.

 

Abstract

This review article offers A brief overview of the most current advancements in synthesis methods and with regard to the pharmacological effects of quinazolinone derivatives. A heterocyclic hybrid quinazolinone having the chemical formula C8H6N2O. It is composed of rings that have been fused together i.e benzene and pyrimidine. The production of quinazolinone derivatives can be accomplished using a variety of methods, such as the Aza-diels-alder reaction, Aza-witting reaction, reaction aided by microwaves, metal-mediated synthesis, palladium-catalyzed reaction, copper-catalyzed reaction, ultrasound-promoted reaction, oxidative cyclization, reagent refluxing, one-pot synthesis, and aqueous media. This review paper included a wide spectrum of pharmacological activities, including a wide range of antibacterial, anti-inflammatory, and analgesic properties of quinazolinone derivatives as well as anti-cancer and anti-oxidant properties were covered in this study.

Keywords: Anti-cancer, anti-inflammatory, anti-oxidant, anti-microbial, pharmacological activity, quinazolinone, synthetic methods.

 

 

INTRODUCTION

 

Quinazolinone is a heterocyclic hybrid with the chemical formula C8H6N2O. It is made up of benzene and pyrimidine rings that have been fused together. Due to their easy accessibility, varied chemical reactivity and wide variety of biological processes, including anti-fungal, anti-tumor, anti-hypertensive, anti-cancer, anti-HIV, anti-inflammatory 1-3, anti-bacterial4, and anti-folate5, quinazolin-4(3H)-one are of incredible interest. This wide range of pharmacological activities has been made even easier by the quinazolinones' synthetic techniques which include the Aza-diels-alder reaction, Aza-witting reaction, reaction aided by microwavesmetal-mediated synthesis, palladium-catalysed reaction, copper-catalysed reaction, ultrasound-promoted reaction, reagent refluxing, one-pot-synthesis, oxidative cyclization and aqueous media This extensive study outlines the chemistry, biological assessment, and significant effects of the several substituted quinazolinone derivatives. This overall study provides a foundation for future research on modifications to the quinazolinone structure and its application in drug research and discovery by providing an overview of the different substituted quinazolinone derivatives, their chemistry, biological assessment, and key medicinal uses.

Synthetic method of quinazolinone 

Aza-diels-alder reaction

This study describes for the first time the use of 2H-indazole as a diene partner in an aza hetero-Diels-Alder reaction that produces highly substituted 4-aminoquinolines via an H-H approach. Additionally, a tandem one-pot technique has been established, beginning with 2-azidobenzaldehyde by the synthesis of 2C6.

Aza-wittig reaction

In this study, Theaza-Wittig catalytic reaction using the catalytic cycle of phosphine and phosphine oxide was explored. The aza-Wittig reaction can be carried out with just a catalytic amount of triphenylphosphine and the tetramethyl disiloxane/titanium tetraisopropoxide  reductant system with good yields because the by-product triphenylphosphine oxide was reduced in-situ to triphenylphosphine (Ph3P) with good chem selectivity7

Microwave-assisted synthesis 

In this study, 4-(1H-benzo[d]imidazol-2-ylthio)-6-methoxypteridine was synthesized via copper-catalyzed cascade couplings in water heated by microwaves8.

The interaction of 6-Iodo-2-undecylquinazolin-4(3H)-one (2) with various alkyl halides is discussed in this study. When a molecule was hydrazinolyzed, it produced acetohydrazide, which, when combined with various carbon electrophiles, produced 2- undecyl-4(3H)-quinazolinone derivatives whether used conventionally or with microwave assistance9.

Metal-mediated reaction

Palladium-catalyzed reaction

 In order to create 1,3-diaryl-6H pyrazino[2,1-b]quinazolin-6-one in water, a unique cyclization, aromatization, and cascade C-C coupling of 2-(4 oxoquinazolin-3(4H)-yl) acetonitrile derivatives with arylboronic acids have been carried out in a single pot using palladiumexplored10.

Copper-catalyzed reaction

In order to make quinazolin-4-ones, this publication described a unique, Imidoylative cross-coupling/ cyclocondensation process involving amines and 2-isocyanobenzoates catalyzed by copper. Anisole is a suggested sustainable solvent for the reaction, which uses Cu (II) acetate as a catalyst and works well in combination with a moderate base. The reaction does not require microwave heating, dry environments or inert atmosphere for best results.11.

Ultrasound-promoted synthesis

In this study, A carboxylic acid, an anthranilic acid, and a primary aromatic amine were condensed with an ionic liquid (BMImBF4) while being exposed to ultrasound to create 4(3H)-quinazolinones. The benefits of this approach include a straightforward catalyst system, improved yields, a lack of organic solvent, and a straightforward synthesis process12.

In this study, 4(3H) quinazoline derivatives were made from 2 aminobenzonitrile and acyl chlorides in solvent-free condition and with the aid of microwave or ultrasonic radiation and Yb(OTf)3 (10 mol%). This research demonstrated a Niementowski-like reaction induced by ultrasound13.

Oxidative cyclization

In this study, oxidative conditions were used for the first time to synthesize fused quinazolinones from N-pyridylindoles, and a combination of K2S2O8 and DIB [(diacetoxy)iodo]benzenegenerated moderate to high yields of 11H-pyrido[2,1-b]quinazolin-11-one derivatives. An in-situ generated 2-hydroxy-1-(pyridin-2-yl) indolin-3-one is believed to be the primary chemical step. It experienced a C-C bond cleavage to yield an electrophilic C-3 site in N-pyridyl indole. It then undergoes cyclization as a result of pyridyl nitrogen's nucleophilic assault. This metal-free reaction has a wide substrate range, is easily operationalized, and takes little time to complete14.

In this study, 2-aryl quinazolinones and activated aldehydes underwent a C-H hyroxyalkylation reaction with ruthenium(II) catalysis in a redox-neutral environment. This procedure permits the C-H addition and subsequent intramolecular cyclization to form biologically active tetracyclic isoindoloquinazolinones in the presence of Cu(OAc)2, an external oxidant15.

Reagent refluxing

This study produced many amino acids that were coupled to quinazolinone-Schiff bases and then used reagent refluxing to describe them analytically and spectroscopically16.

One-pot synthesis

 In this paper Using [Cp*IrCl2]2 (Cp*pentamethyl cyclopentadienyl) as a catalyst in a one-pot oxidative cyclization process with o-aminobenzamides to produce quinazolinones under hydrogen transfer conditions17.

In aqueous media

More SV et al., uses water at room temperature, ceric (IV) substituted o-phenylenediamines, aryl/heteroaryl 1,2-diketones, alkyl/aryl 1,2-diketones, and ammonium nitrate (CAN) as a catalystand aryl/heteroaryl 1,2- diketones to produce quinoxaline derivatives. 

Numerous organic oxidative reactionsuse the one-electron oxidant CAN. This approach is cost-effective, efficient, and high-yielding.

Pharmacological activities of quinazolinone

Anti-microbial activity

A highly effective and flexible synthetic method was used to create five annelated quinazoline derivatives18,19.

Through the reaction of 2-(oaminophenyl) indole with a variety of arylaldehydes, indolo[1,2c]quinazoline derivatives were produced in good yields and demonstrated activity against a number of gram-positive, gram-negative, and pathogenic fungal strains, including Staphylococcus aureus, Bacillus subtilis, and Streptococcus pyogenes. Reference substances included ampicillin and ketoconazoleThe antibacterial activity of 6-iodo-2-thienylquinazolin-4(3H)-one and its fused heterocyclic counterparts was investigated. The antibacterial activity of compounds 4, 8, 14, and 24 was remarkably broad- spectrum20. The antibacterial activity of 6-iodo-2-thienylquinazolin-4(3H)-one and its fused heterocyclic counterparts was investigated. The antibacterial activity of compounds 8, 14, and 24 was remarkably broad-spectrum. Utilizing the traditional microdilution method, it was discovered that synthesized derivatives have antimicrobial activities against three species of Gram-negative bacteria, including Escherichia coli, Pseudomonas aeruginosa, Salmonella enteritidis, and three species of Gram-positive bacteria, including S. aureus, B. subtilis, and Listeria monocot genes21.

It was created using pyridine, anthranilic acid, and derivatives of 4-substituted and unsubstituted benzoyl chloride. By combining 2-(4-substituted)Phenyl-3-amino Quinazoline -4-3(H)one and 2-Phenyl-3-amino Quinazoline-4-3(H)one with various substituted aromatic aldehydes in glass vials and heating them in an oil bath at 80 degrees Celsius, a set of six Schiff bases were created.  Structure has been clarified using spectroscopic methods (Figure 6)22.

Anti-inflammatory and analgesic

In this study, two A number of compounds of 2,4,6-trisubstituted quinazolines were created and assessed for their analgesic and anti-inflammatory properties. Significant action was produced by fifteen compounds. Four substances were discovered to be analgesics. A total of seven substances showed their capacity to reduce both pain and inflammation. Acute toxicity tests on the compound revealed a good safety margin (Figure 7)23Molecular docking, biological assessment, and synthesis of the novel series of spiro [(2H, 3H) quinazoline -2,1'-cyclohexan]-4(1H)-one derivatives as analgesics and anti-inflammatory drugs. There are nineteen different compounds were assessed as analgesics and anti-inflammatory drugs. After experiments on animals.

There are six derivatives shows good pharmacological activities with gastrointestinal, and eleven compound found as anti-inflammatory agents and active against COX-2 (Figure 8)24. To design, synthesis and biological evaluation of quinazoline derivatives as ant- trypanosomatid and anti-plasmodial agents. Biological evaluation of quinazoline-2,4,6-triamine derivatives as Agents that were anti-plasmodial, anti-leishmanial, and trypanocidal were discovered. Leishmania Mexicana promatigotes and bloodstream trypomastigotes of T. cruzi (NINOA and INC-5 strains) were evaluated for in vitro by all substances. (MHOM/BZ/61/M379 strain). There are 5, 6, 8, and 9 were found most active biological activity (Figure 9)25. To evaluate the 2,4-diamino substituted 5,6-dihydrobenzo [h] Quinazoline's antiplatelet/antiphlogistic properties. In this study, the chemical 5a-5h was shown to have analgesic and anti-inflammatory effects on rat paw oedema (Figure 10)26.

Quinazoline as anti-cancer

Using the synthon 4-(thiophen-2-yl)-3,4,5,6-tetrahydrobenzo[h]quinazoline-2(1H)-thione, certain newly Quinazoline and thioxopyrimidine derivatives that were produced were assessedfor cytotoxicity and anti-HIV activity. The most potent cytotoxic activity was demonstrated by few compounds against cell lines of melanoma (G361 and SK-MEL-28), leukemia (HL60, U937, and K562), neuroblasts (GOTO and NB-1), and normal cell carcinoma (W138). (Figure 11)27. This study created, synthesized 27, and physiologically assessed new quinazoline derivatives with an IC50 range of 3.35 to5.59 mg/ml as possible anticancer drugs. 

The substantial inhibitory activity of two compounds in comparison to other of the same series was further substantiated by molecular docking studies. These studies also contribute to a more detailed understanding of the numerous interactions between the ligands and the enzymes' active areas, which in turn aids in the development of new, powerful inhibitors28. The cytotoxic activity of the suggested quinazoline derivatives was evaluated using three cell lines: the human cervix cell line (HELA), human liver cell line (HEPG2), and human breast cell line (MCF-7). With an IC50 range of 3.35 to 6.81 mg/ml, all investigated compounds demonstrated strong and specific action against breast cancer (MCF-7) cells (Figure 12) [28]. In this study, 26 synthetic compounds were tested for their efficacy against the HeLa and MDA-MB231 cancer cell lines. Three of these compounds were shown to have the strongest anticancer effects and to likely act through the EGFR-TK pathway quinazoline derivatives (Figure 13)29.

This study designed, synthesized a total of eight compounds, and assessed the biological effects of three novel quinazoline derivatives as cytotoxic agents on a lymphoma cell line in vitro (Figure 14)30.

Quinazoline as anti-oxidant 

Based on three antioxidant experiments, benzoquinazolines showed antioxidant activity. The impacts of Methoxy (a group that donates electrons), hydrazine (which supplies hydrogen atoms), and phenyl (an electron-rich moiety) can be credited for the compounds 3, 9, and 15 having the highest FRAP, DPPH radical scavenging activity, and lowering power capabilities, in that order. Future studies to develop novel, more potent antioxidants chemicals will take into account the findings of the molecular docking and SAR investigations (Figure 15)31. Twenty-seven new quinazolinones derivatives were synthesized, and three of them (compounds 1, 2, and 3) had EC50 values of 0.220, 0.275, and 0.380 mg, respectively, when tested for high antioxidant activity using DPPH.  Four of these substances demonstrated outstanding antiproliferative properties (Figure 16).

Quinazolinone as anti-bacterial

The investigated substances in this study were also examined for their ability to inhibit the growth of S. aureus and E. coli strains at 200 g/ml and 1 mg/ml, respectively. At higher tested concentrations, the tested compounds outperformed standard lincomycin in terms of activity against S. aureus. None of the compounds are as effective against E. coli as ceftazidime in its conventional form (Figure 17)32.

 

CONCLUSIONS

 

It's crucial to remember that the combination of N-heterocyclic quinazolinone and its derivatives requires more rigid and complex structures. Fundamental techniques for the production of chemicals that are heterocyclic include the Aza-synthetic method, refluxing, and oxidative cyclization, which are still widely used for the synthesis of quinazolinone derivatives. This review article, however, summarized a number of novel synthetic techniques, such as the Aza-diels-alder reaction, Aza-witting reaction, metal-mediated reaction, and microwave-assisted reaction, palladium-catalyzed reaction, copper-catalyzed reaction, ultrasound-promoted reaction, One-pot synthesis, reagent refluxing, and oxidative cyclization, and aqueous media, and these techniques would improve the synthetic research on quinazolinone. Pharmacological activities like those that are anti-bacterial, anti-inflammatory, analgesic, anti-cancer and anti-oxidant were also summarized in this review article. It can be inferred from the research progress above that in the future, drug design will focus on increasing activity by incorporating various active groups and novel techniques.

 

ACKNOWLEDGEMENTS


Authors would like to present acknowledgements
to Sana'a University – Faculty of Pharmacy, Yemen for their invaluable support and guidance throughout this study journey. 

 

AUTHOR'S CONTRIBUTIONS

 

Meftah ON: Research topic idea, manuscript writing , literature review and final manuscript checking. Ali A: critical evaluation. Alkaf A: Manuscript checking.

Final manuscript was checked and approved by all authors.

 

DATA AVAILABILITY

 

The data will be available to anyone upon request from the corresponding author.

 

CONFLICT OF INTEREST


None to declare. 

 

REFERENCES

 

  1. Ahmad Mir S, Meher RK, Baitharu I, Nayak B. Molecular dynamic simulation, free binding energy calculation of Thiazolo-[2,3-b]quinazolinone derivatives against EGFR-TKD and their anticancer activity. Results Chem 4(April) 2022; 100418.https://doi.org/10.1016/j.rechem.2022.100418
  1. Alafeefy AM, El-Azab AS, Mohamed MA, et al. Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening. J Saudi Chem Soc 2011; 15(4): 319–325.https://doi.org/10.1016/j.jscs.2011.07.005
  1. Alafeefy AM, Kadi AA, Al-Deeb OA, et al. Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives. European Journal of Medicinal Chemistry 2010; 45(11), 4947–4952. https://doi.org/10.1016/j.ejmech.2010.07.067
  1. Amin KM, Kamel MM, Anwar MM, Khedr M, Syam YM. (2010). Biological evaluation and molecular docking of novel series as anti-inflammatory and analgesic agents. European Journal of Medicinal Chemistry 2010; 45(6): 2117–2131. https://doi.org/10.1016/j.ejmech.2009.12.078
  2. Zayed MF, Hassan MH. Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents. Drug Res (Stuttg) 2013; 63(04): 210-215.https://doi.org/10.1055/s-0033-1337929
  1. Asif M. Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives. Int J Med Chem 2014, 1–27.https://doi.org/10.1155/2014/395637
  1. Brullo C, Rocca M, Fossa P, et al. Bioorganic and medicinal chemistry letters and antiplatelet/antiphlogistic activities evaluation. Bioorg Med Chem Lett 2012; 22(2), 1125–1129. https://doi.org/10.1016/j.bmcl.2011.11.103
  2. Choi JH, Kim K, Oh H, et al. Ru(ii)-Catalyzed C-H addition and oxidative cyclization of 2-aryl quinazolinones with activated aldehydes. Org Biomol Chem 2020; 18(47), 9611–9622. https://doi.org/10.1039/d0ob01663b
  3. Collet JW, Nol EA, Van Der, et al. Synthesis of quinazolin-4-ones by copper catalyzed isocyanide insertion synthesis of quinazolin-4-ones by copper catalyzed isocyanide insertion. J Org Chem 2020; (85)11: 7378–7385. https://doi.org/10.1021/acs.joc.0c00771
  4. Corona P, Loriga M, Costi MP, et al. Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: Evaluation of in vitro anti-cancer and anti-folate activities. European J Med Chem 2008; 43(1): 189–203.https://doi.org/10.1016/j.ejmech.2007.03.035
  1. El-azab AS, Al-omar MA, Abdel-aziz AA, et al. Synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents : Molecular docking study. European J Med Chem 2010; 45(9): 4188–4198.https://doi.org/10.1016/j.ejmech.2010.06.013
  1. Farooq S, Mazhar A, Ihsan-Ul-Haq, Ullah, N. One-pot multicomponent synthesis of novel 3, 4-dihydro-3-methyl-2(1H)-quinazolinone derivatives and their biological evaluation as potential antioxidants, enzyme inhibitors, antimicrobials, cytotoxic and anti-inflammatory agents. Arabian J Chem 2020; 13(12), 9145–9165.https://doi.org/10.1016/j.arabjc.2020.10.039
  1. Fiorito S, Taddeo VA, Epifano F, Genovese S. Ultrasound ‐ promoted synthesis of 4 ( 3 H ) ‐ quinazolines under Yb (OTf) 3 catalysis. Archive Org Chem 2016.https://doi.org/10.3998/ark.5550190.p009.710
  1. Galindo-sevilla N, Nogueda-torres B, Su E, et al. Synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents. European J Med Chem Design 2015; 96; 296–307.https://doi.org/10.1016/j.ejmech.2015.04.028
  1. Ganguli S. One-pot synthesis of novel quinazoline derivatives and their antimicrobial activity. Int J Pharmacy Pharmaceutical Sci 2012; 4(4):434-440.
  2. Garia A, Jain N. (2019). Transition metal-free synthesis of fused quinazolinones by oxidative cyclization of N-pyridylindoles J Org Chem 2019; 84(15):9661–9670.https://doi.org/10.1021/acs.joc.9b01170
  1. Hekal MH, El-azm FSMA, Atta-allah SR. Ecofriendly and highly efficient microwave- induced synthesis of novel quinazolinone-undecyl hybrids with in vitro antitumor activity. Synth Commun 2019; 0(0), 1–12.https://doi.org/10.1080/00397911.2019.1637001
  1. Hour MJ, Lee KH, Chen TL, et al. Molecular modelling, synthesis, cytotoxicity and anti-tumour mechanisms of 2-aryl-6-substituted quinazolinones as dual-targeted anti-cancer agents. British J Pharmacol 2013; 169(7), 1574–1586. https://doi.org/10.1111/bph.12233
  2. Ke F, Liu C, Zhang P, Xu J, Chen X. Efficient and selective microwave-assisted copper-catalyzed synthesis of quinazolinone derivatives in aqueous. Synthetic Communic 2018; 48(24): 3089–3098.https://doi.org/10.1080/00397911.2018.1533974
  1. Marzouk M, Almehizia AA. SC. Pharmacological Reports 2019. https://doi.org/10.1016/j.pharep.2019.04.003
  2. Mohamed YA, Amr ABDEE, Mohamed SF, et al. Cytotoxicity and anti-HIV evaluations of some new synthesized quinazoline and thioxopyrimidine derivatives using as synthon 2012; 124(3): 693–702.
  3. Nanthakumar R, Muthumani P, Girija K. Anti-inflammatory and antibacterial activity study of some novel quinazolinones. Arabian J Chem 2014; 7(6): 1049–1054. https://doi.org/10.1016/j.arabjc.2010.12.035
  1. Nasab RR, Mansourian M, Hassanzadeh F. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. Res Pharm Sci 2018; 213–221.https://doi.org/10.4103/1735-5362.228942
  1. Omprakash B, Fulchand R, Narayan D, Sachin S. Ultrasound promoted and ionic liquid catalyzedcyclocon- densation reaction for the synthesis of 4 (3H)-Quinazolinones 2010; 4: 2009–2011.https://doi.org/10.1002/cjoc.201090037
  1. Pan JY, Lin CC, Wu CJ, Chang JP. (2016). Early and intermediate-term results of the extracardiac conduit total cavopulmonary connection for functional single-ventricle hearts. J Formosan Med Assoc 115(5), 318–324.https://doi.org/10.1016/j.jfma.2015.12.011
  1. Rakesh KP, Kumara HK, Ullas BJ, Shivakumara J, Channe Gowda D. Amino acids conjugated quinazolinone-Schiff’s bases as potential antimicrobial agents: Synthesis, SAR and molecular docking studies. Bioorg Chem 2019; 90, 103093. https://doi.org/10.1016/j.bioorg.2019.103093
  2. Rohini R, Reddy M, Shanker K, et al. (2010). Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines. European J Med Chem 2010; 45(3), 1200–1205.https://doi.org/10.1016/j.ejmech.2009.11.038
  1. Verma SK, Verma R, Rakesh KP, Gowda DC. Design, synthesis and structure-activity studies of amino acids conjugated quinazolinone-Schiff’s bases as potential antioxidant and anti-inflammatory agents. European J Med Chem Rep 2022;100087.https://doi.org/10.1016/j.ejmcr.2022.100087
  1. Vidyacharan S, Sagar A, Sharada DS. (2015). A new route for the synthesis of highly substituted 4-aminoquinoline drug like molecules via aza hetero-Diels-Alder reaction. Organic and Biomolecular Chemistry 2015; 13(28), 7614–7618. https://doi.org/10.1039/c5ob01023c
  2. Wang L, Wang Y, Chen M, Ding MW. (2014). Reversible P(III)/P(V) redox: Catalytic aza-Wittig reaction for the synthesis of 4(3H)-quinazolinones and the natural product vasicinone. Advanced Synth Catal 2014; 356(5): 1098–1104. https://doi.org/10.1002/adsc.201300950
  3. Zhang Y, Xiong W, Chen L, et al. Palladium-catalyzed cascade reactions in aqueous media: Synthesis and photophysical properties of pyrazino-fused quinazolinones. Organic Chem Front 2021; 8(2): 304–309.https://doi.org/10.1039/d0qo01244k
  1. Zhou J, Fang J. (2011). One-pot synthesis of quinazolinones via iridium-catalyzed hydrogen transfers. J Org Chem 2011; 76(19): 7730–7736.https://doi.org/10.1021/jo201054k